Sarcoma  >>  EGFRvIII CAR  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
EGFRvIII CAR / National Cancer Institute, Gilead
INTERCEPT, NCT03283631: Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM

Terminated
1
2
US
EGFRvIII-CARs
Gary Archer Ph.D., National Cancer Institute (NCI), Duke Cancer Institute
Recurrent Glioblastoma, Recurrent Gliosarcoma
09/19
06/20

Download Options